117 related articles for article (PubMed ID: 15157799)
1. The force required to remove the frameless 0-suture IUD anchoring system: comparison between pre- and postmenopausal women.
Wildemeersch D
Contraception; 2004 Jun; 69(6):513-5. PubMed ID: 15157799
[TBL] [Abstract][Full Text] [Related]
2. The reliability of the anchoring concept for suspension of bioactive substances in the human uterus evaluated by measuring the removal force: results after long-term use.
Batár I; Wildemeersch D
Contraception; 2004 Jun; 69(6):501-3. PubMed ID: 15157797
[TBL] [Abstract][Full Text] [Related]
3. Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.
Andrade AT; Souza JP; Andrade GN; Rowe PJ; Wildemeersch D
Contraception; 2004 Aug; 70(2):173-7. PubMed ID: 15288225
[TBL] [Abstract][Full Text] [Related]
4. New frameless and framed intrauterine devices and systems - an overview.
Wildemeersch D
Contraception; 2007 Jun; 75(6 Suppl):S82-92. PubMed ID: 17531623
[TBL] [Abstract][Full Text] [Related]
5. Use of frameless intrauterine devices and systems in young nulliparous and adolescent women: results of a multicenter study.
Wildemeersch D; Jandi S; Pett A; Nolte K; Hasskamp T; Vrijens M
Int J Womens Health; 2014; 6():727-34. PubMed ID: 25125987
[TBL] [Abstract][Full Text] [Related]
6. Three-year efficacy and acceptability of the GyneFix 200 intrauterine system.
Cao X; Zhang W; Zhao X; Lin N; Wang L; Li C; Song L; Zhang W; Zhang Z; Wildemeersch D
Contraception; 2004 Mar; 69(3):207-11. PubMed ID: 14969668
[TBL] [Abstract][Full Text] [Related]
7. [Randomized comparative study of GyneFix IN and TCu 380A intrauterine devices].
Wu S; Hu J; Wu M
Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):345-8. PubMed ID: 10806672
[TBL] [Abstract][Full Text] [Related]
8. [Intrauterine copper contraceptive implants].
Van Kets H; Thiery M; Wildemeersch D; Delbarge W; Vrijens M; Van der Pas H; Depypere H; Parewijck W; Temmerman M; Van Trappen Y; Van den Ostende G
Contracept Fertil Sex; 1996 Dec; 24(12):908-11. PubMed ID: 9026279
[TBL] [Abstract][Full Text] [Related]
9. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
[TBL] [Abstract][Full Text] [Related]
11. Comparative study on contraceptive efficacy and clinical performance of the copper/low-density polyethylene nanocomposite IUD and the copper T220C IUD.
Yu J; Li J; Li HG; Li JX; Xie CS; Zhu CH
Contraception; 2008 Oct; 78(4):319-23. PubMed ID: 18847581
[TBL] [Abstract][Full Text] [Related]
12. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
Sanches L; Marchi NM; Castro S; Juliato CT; Villarroel M; Bahamondes L
Contraception; 2008 Nov; 78(5):365-9. PubMed ID: 18929732
[TBL] [Abstract][Full Text] [Related]
13. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age.
Bahamondes L; Faundes A; Sobreira-Lima B; Lui-Filho JF; Pecci P; Matera S
Contraception; 2005 Nov; 72(5):337-41. PubMed ID: 16246658
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous breakage and expulsion of a stem fragment of levonorgestrel intrauterine system (Mirena) following duplicate insertion.
Jindal S; Sharma SS; Ikomi A
Arch Gynecol Obstet; 2009 Jan; 279(1):95-7. PubMed ID: 18949478
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a mini version of the frameless GyneFix intrauterine system (IUS) with effective copper surface area of 200 mm2. dirk.wildemeersch@contrel.be.
Wildemeersch D; Cao X; Zhang W; Zhao X; Lin N; Wang L; Li C; Song L; Zhang W; Zhang Z; Delbarge W
Contraception; 2002 Oct; 66(4):237-41. PubMed ID: 12413618
[TBL] [Abstract][Full Text] [Related]
16. Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study.
Ng YW; Liang S; Singh K
Contraception; 2009 Jan; 79(1):24-8. PubMed ID: 19041437
[TBL] [Abstract][Full Text] [Related]
17. Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface area of 200 mm2 and users of a copper-levonorgestrel-releasing intrauterine system.
Wildemeersch D; Rowe PJ
Contraception; 2004 Aug; 70(2):169-72. PubMed ID: 15288224
[TBL] [Abstract][Full Text] [Related]
18. Commentary - Lyus R, Lohr P, Prager S. Use of Mirena LNG-IUS and Paragard CuT380A intrauterine devices for nulliparous women [Contraception 2010;81:367-371].
Wildemeersch D
Contraception; 2011 Feb; 83(2):184-6; author reply 186-7. PubMed ID: 21237345
[No Abstract] [Full Text] [Related]
19. Intrauterine devices and intrauterine systems.
ESHRE Capri Workshop Group
Hum Reprod Update; 2008; 14(3):197-208. PubMed ID: 18400840
[TBL] [Abstract][Full Text] [Related]
20. Copper intrauterine device use by nulliparous women: review of side effects.
Hubacher D
Contraception; 2007 Jun; 75(6 Suppl):S8-11. PubMed ID: 17531622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
